SCHEMBL6573142

SCHEMBL6573142

CC(=O)NCCC(C)S(=O)(=O)O.[CaH2]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
MAPK1 P28482 1/20 0.46
HIF1A Q16665 1/20 0.46
MTNR1A P48039 2/20 0.42
MTNR1B P49286 2/20 0.42
PAOX Q6QHF9 3/20 0.39
TSHR P16473 1/20 0.39
ADRA1A P35348 1/20 0.38
ALDH1A1 P00352 2/20 0.38
FOLH1 Q04609 1/20 0.35
MMP1 P03956 2/20 0.35
MMP2 P08253 2/20 0.35
MMP9 P14780 2/20 0.35
MMP14 P50281 2/20 0.35
ADAM17 P78536 1/20 0.35
ZDHHC7 Q9NXF8 1/20 0.34
ANPEP P15144 3/20 0.33
RNPEP Q9H4A4 2/20 0.33
DNPEP Q9ULA0 2/20 0.33
CHRNB2 P17787 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4761177 0.98 KDM4E (0.48) KDM4EMAPK1HIF1AMTNR1AMTNR1B
SCHEMBL3201604 0.79 ANPEP (0.38) ANPEPRNPEPDNPEPCHRNB2CHRNB4
SCHEMBL6571894 0.78 MTNR1A (0.41) KDM4EMAPK1HIF1AMTNR1AMTNR1B
SCHEMBL14375749 0.77 KDM4E (0.41) KDM4EMAPK1HIF1AMTNR1AMTNR1B
SCHEMBL196485 0.76 ZDHHC20 (0.49) MAPK1TSHRALDH1A1ANPEPRNPEP
SCHEMBL16789546 0.74 TP53 (0.34) ALDH1A1
SCHEMBL13374704 0.74
SCHEMBL800814 0.73
SCHEMBL28655580 0.73 TDP1 (0.56)
SCHEMBL15255388 0.72 TP53 (0.33) HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6265437-B1 ALCOHOLISM LIPHA (FR) 2001-07-24 US claimed
CN-1182837-C Orally administrable immediate and prolonged-release Galenic form comprising absorption-promoting agent and use of this absorption-promoting agent Ĭ��ר���ɷ����޹�˾ 2005-01-05 CN disclosed
EP-1410791-A1 Orally administrable galenic form comprising metformine and an absorption-promoting agent MERCK PATENT GmbH (DE) 2004-04-21 EP disclosed
US-6514524-B1 Improved absorption of hydrophilic ingredients because of particular excipients; calcium 3-acetylamino-1-propane sulfonate (calcium acamprosate); polysorbates, fatty ethers or esters of PEG, polyglycolysed glycerides MERCK PATENTGESELLSCHAFT MIT (DE) 2003-02-04 US disclosed
US-6426087-B1 GALENIC FORMS; SUSTAINED RELEASE MERCK PATENT GESELLSCHAFT MIT (DE) 2002-07-30 US disclosed
US-6265437-B1 ALCOHOLISM LIPHA (FR) 2001-07-24 US disclosed